<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

CAR-T Poised to Create ‘Paradigm Shift’ in Non-Hodgkin Lymphoma

Written by Healio on February 15, 2022

Since the approval of the first chimeric antigen receptor T-cell therapy, the research community has grappled with a crucial question: Is the modality appropriate for earlier use by patients with certain types of cancer?

Topics: Press Coverage

Comments